Clinical and Translational Medicine (Jun 2020)
Novel blood‐based tumor mutation algorithm and nomogram predict survival of immune checkpoint inhibitor in non‐small‐cell lung cancer: Results from two multicenter, randomized clinical trials
- Yunfang Yu,
- Yongjian Chen,
- Anlin Li,
- Qiyun Ou,
- Qingjian Li,
- Yang Gu,
- Dagui Lin,
- Wenda Zhang,
- Jingshu Wang,
- Xudong Tang,
- Zhihua Li,
- Hai Hu,
- Herui Yao
Affiliations
- Yunfang Yu
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Medical Oncology Phase I Clinical Trial Centre Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou Guangdong China
- Yongjian Chen
- Department of Medical Oncology The Third Affiliated Hospital of Sun Yat‐sen University Guangzhou China
- Anlin Li
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Medical Oncology Phase I Clinical Trial Centre Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou Guangdong China
- Qiyun Ou
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Medical Oncology Phase I Clinical Trial Centre Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou Guangdong China
- Qingjian Li
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Medical Oncology Phase I Clinical Trial Centre Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou Guangdong China
- Yang Gu
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Medical Oncology Phase I Clinical Trial Centre Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou Guangdong China
- Dagui Lin
- State key laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Sun Yat‐sen University Cancer Center Guangzhou China
- Wenda Zhang
- Guangdong Medical University Zhanjiang Guangdong China
- Jingshu Wang
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Medical Oncology Phase I Clinical Trial Centre Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou Guangdong China
- Xudong Tang
- Guangdong Medical University Zhanjiang Guangdong China
- Zhihua Li
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Medical Oncology Phase I Clinical Trial Centre Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou Guangdong China
- Hai Hu
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Medical Oncology Phase I Clinical Trial Centre Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou Guangdong China
- Herui Yao
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Department of Medical Oncology Phase I Clinical Trial Centre Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou Guangdong China
- DOI
- https://doi.org/10.1002/ctm2.53
- Journal volume & issue
-
Vol. 10,
no. 2
pp. n/a – n/a
Abstract
No abstracts available.